Taking AVONEX since 2001
Whatever your passion,
AVONEX helps protect it longer
At 2 years, people taking AVONEX were 37% less likely to have increased physical
disability, compared with people who weren’t treating their MS
In a separate 3-year study, people taking AVONEX were 44% less likely to have a
second flare-up, compared with people who weren’t treating their MSa
In the 10-year follow-up of the same 3-year study:
• People who started AVONEX early were 39% less likely to have a second flare-up,
compared with people who delayed treatmentb-d
• 8 out of 10 people taking AVONEX were still active in their daily lives at 10 years,
with EDSS scores below 3.0b,e
• 2 out of 3 people taking AVONEX had no cognitive decline between years 5 and 10,
on a test measuring memory, attention, and mental processing speed.b It is unknown
whether the effects on cognition seen in this study were caused by AVONEX.
Safety and efficacy of treatment with AVONEX beyond three years is not known
Talk to your doctor to find out if AVONEX is right for you
Try AVONEX FREE for one month.
Visit AVONEX.com today to get started.
Focus on the future
a A 3-year study of people who had a first attack and lesions consistent with MS on their MRIs.
b A 10-year-follow-up of a 3-year study of people who had a first attack and lesions consistent with MS on their MRIs.
c People who started AVONEX early began treatment within 30 days of their first flare-up. People who delayed
treatment started AVONEX an average of 2.5 years after their first flare-up.
d This includes all people in this study at 10 years, regardless of whether they were taking AVONEX, another
therapy, or no therapy.
e The Expanded Disability Status Scale (EDSS) is a tool used by physicians to measure disability in people with MS.